StockWatch
·

Sunshine Biopharma Inc. Q3 FY25 Results

SBFMQ3 FY25 Results
MetricValue ($ M)Q2 FY25Q3 FY24
Revenue9.420.1%11.6%
Total Income9.420.1%11.6%
Expenditure10.508.4%10.1%
PBT-1.0248.5%4.1%
Net Profit-0.8850.3%26.7%
OPM-11.54%10.30pp1.58pp
NPM-9.38%9.43pp4.81pp
EPS-0.1951.3%79.8%
View full financials

Informational and educational content only. Not investment advice.